The University Health System is employing a therapy for the treatment of prostate cancer developed by medical company Galil Medical.
The technique, called cryotherapy, kills cancer cells by freezing them and uses thin needles in outpatient settings.
The procedure has very few side effects, including pain and frequency of urination. The treatment can be used as a follow-up to therapy or as a first-time treatment for cancer localized in the prostate.
Prostate cancer is the most common form of cancer in men and the second-leading cause of male cancer deaths, according to the American Cancer Society.
The cryotherapy procedure involves the creation of a three-dimensional computer image of the diseased prostate which doctors use to precisely arrange a series of needles around the cancerous tissue. Once the needles are in place and the patient is anesthetized, the surgeon uses high-pressure argon gas to create an ice ball exactly surrounding the gland, killing the prostate cells at minus 40 degrees Celsius.
- Compiled by Justin Bernick
Read More
Deeds requested a range of records. Here’s what he actually got.
By Nicolas Biernacki | YesterdayDeeds acknowledged that the University’s FOIA release did not include all of the materials that he requested.
Faculty Senate passes resolution calling for presidential search finalists to ask for pause
By Cecilia Mould | YesterdayTwo additional discussions focused on the extension of the Representation and Governance committee — a temporary committee established in Spring 2025 — and a new course materials platform the University plans to introduce, titled One Access.
‘A great win’: Mahoney testified for senators on Justice Department agreement Dec. 1
By Luca Bailey | 2 days agoMahoney hailed the agreement as “a great win for the Commonwealth” and for the University despite multiple senators having expressed discontent with the agreement through letters sent to the University.
